New Jersey · 2026-2027 Regular Session · Bill
S 322: Establishes tianeptine as Schedule II controlled dangerous substance.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 322 is a bill introduced in the New Jersey Senate on January 13, 2026. According to its official title, it concerns: Establishes tianeptine as Schedule II controlled dangerous substance. Primary sponsor: Doug Steinhardt (Republican), Troy Singleton (Democratic). It lists 1 additional sponsor. Most recent recorded action (January 13, 2026): Withdrawn Because Approved P.L.2025, c.249.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Doug Steinhardt | Primary sponsor | Republican | Senate | 23 |
| Troy Singleton | Primary sponsor | Democratic | Senate | 7 |
| Paul Moriarty | Co-sponsor | Democratic | Senate | 4 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Withdrawn Because Approved P.L.2025, c.249.
- Introduced in the Senate, Referred to Senate Judiciary Committee